Michael Alifrangis

Michael Alifrangis

Associate Professor

Member of:

  • DRUGS team

ORCID: 0000-0002-3835-3333

Publication year:
All
11 - 13 out of 13Page size: 10
  1. 2018
  2. Published

    Prevalence and risk factors for CTX-M gram-negative bacteria in hospitalized patients at a tertiary care hospital in Kilimanjaro, Tanzania

    Sonda, T., Kumburu, H., van Zwetselaar, M., Alifrangis, Michael, Mmbaga, B. T., Lund, O., Aarestrup, F. M. & Kibiki, G., 2018, In: European Journal of Clinical Microbiology and Infectious Diseases. 37, 5, p. 897-906 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Whole genome sequencing reveals high clonal diversity of Escherichia coli isolated from patients in a tertiary care hospital in Moshi, Tanzania

    Sonda, T., Kumburu, H., van Zwetselaar, M., Alifrangis, Michael, Mmbaga, B. T., Aarestrup, F. M., Kibiki, G. & Lund, O., 2018, In: Antimicrobial Resistance and Infection Control. 7, 12 p., 72.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Genetic spatiotemporal anatomy of Plasmodium vivax malaria episodes in Greece, 2009-2013

    MALWEST Project, M. P., Mar 2018, In: Emerging Infectious Diseases . 24, 3, p. 541-548 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 Next

ID: 11975